Increased Level of Serum Homocysteine in Vitiligo
Overview
Biotechnology
Pathology
Authors
Affiliations
Background: Vitiligo is an acquired depigmenting disorder caused by the destruction of melanocytes. The exact etiopathogenesis and mechanisms of vitiligo are not fully understood. Vitamin B12 and folic acid levels are decreased in vitiligo, which are the important cofactors required in the metabolism of Homocysteine (Hcy). Consequently, Hcy level increases in the circulation. Therefore, it is possible that increased Hcy plays a role in melanocytes destruction. The aim was to study for any association of vitiligo with serum Hcy level.
Method: A total of 30 vitiligo patients of both sexes and 30 control subjects were enrolled in this study. Sera from patients and controls were assayed for Hcy by Enzyme immunoassay. The collected data were analyzed by SPSS version-16.
Results: The mean serum level of Hcy was significantly higher in patients with vitiligo as compared with healthy controls and its level was high in male patients as compared with female patients. The Hcy level in vegetarian patients was significantly higher as compared with nonvegetarian patients. The Hcy level was also significantly higher in active vitiligo patients as compared with stable vitiligo patients.
Conclusion: An increased serum Hcy may be a precipitating factor for vitiligo in the predisposed individuals. Serum Hcy is related to the gender of patients, activity of disease, and dietary habits of vitiligo patients.
Markers of Metabolic Abnormalities in Vitiligo Patients.
Papaccio F, Ottaviani M, Truglio M, DArino A, Caputo S, Pacifico A Int J Mol Sci. 2024; 25(18).
PMID: 39337683 PMC: 11432710. DOI: 10.3390/ijms251810201.
Risk factors for cardiovascular diseases in patients with vitiligo: an analysis of current evidence.
Liang X, Guo F, Zhang M, Wang C, Lin N, Liu L Ann Med. 2024; 56(1):2326297.
PMID: 39300810 PMC: 11418058. DOI: 10.1080/07853890.2024.2326297.
Vitiligo and insulin resistance as a component of metabolic syndrome: an analysis.
Tekielak A, Pietrauszka K, Miziolek B, Bergler-Czop B Postepy Dermatol Alergol. 2023; 40(4):529-533.
PMID: 37692261 PMC: 10485765. DOI: 10.5114/ada.2023.126871.
Choudhary N, Patel N, Raghuwanshi A, Choudhary N, Agrawal S Cureus. 2023; 15(2):e34772.
PMID: 36909125 PMC: 10005420. DOI: 10.7759/cureus.34772.
Himawan A, Vora L, Permana A, Sudir S, Nurdin A, Nislawati R Adv Healthc Mater. 2022; 12(5):e2202066.
PMID: 36414019 PMC: 11468661. DOI: 10.1002/adhm.202202066.